Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-07-25T09:36:04.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 151 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.6%
    Check dated 2024-07-23T08:27:13.000Z thumbnail image
  6. Check
    8 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-07-19T04:55:34.000Z thumbnail image
  7. Check
    9 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-07-18T04:12:31.000Z thumbnail image
  8. Check
    10 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-07-17T03:10:02.000Z thumbnail image
  9. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T02:00:47.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.